Nexus Oncology has a well-established track record of working with many novel therapeutic approaches.
			Collectively, the clinical research team at Nexus Oncology has conducted in excess of 250 clinical studies in oncology. Our extensive experience with a range of novel therapeutic approaches includes: Oral and i.v. cytotoxic agents Cytostatic agents Targeted therapies Hormonal therapies Gene therapies Vaccines Antibodies Immunomodulators Supportive care therapies
	xxHome xxAbout Nexus Oncology xxExecutive Management xxConsultant Medical Advisors xxBoard of Directors xxServices xxWorking with Nexus Oncology xxUseful Links xxExperience > Therapeutic Approaches xxTumour-type Experience xxCase Studies xxNewsroom xxContact Nexus Oncology xxMeet Nexus Oncology xxVacancies

© Nexus Oncology 2008xxIxxwebsite credits